459
Participants
Start Date
August 31, 2008
Primary Completion Date
February 28, 2009
Study Completion Date
February 28, 2009
Adapalene BPO Gel associated with Doxycyline Hyclate
Adapalene BPO Gel: Topical to the face, once daily in the evening Doxycycline Hyclate: Oral, 1 tablet once daily in the morning. Both during 12 weeks.
Vehicle Gel associated with Doxycycline Hyclate
Vehicle Gel: Topical to the face, once daily in the evening; Doxycycline Hyclate: Oral, 1 tablet once daily in the morning. Both during 12 weeks.
Galderma Investigational Site, Webster
Galderma Investigational Site, Oceanside
Galderma Investigational Site, San Diego
Galderma Investigational Site, Denver
Galderma Investigational Site, Longmont
Galderma Investigational Site, Miami
Galderma Investigational Site, Snellville
Galderma Investigational Site, Chicago
Galderma Investigational Site, Evansville
Galderma Investigational Site, Overland Park
Galderma Investigational Site, Louisville
Galderma Investigational Site, Detroit
Galderma Investigational Site, Fort Gratiot
Galderma Investigational Site, Fridley
Galderma Investigational Site, Omaha
Galderma Investigational Site, Albuquerque
Galderma Investigational Site, Stony Brook
Galderma Investigational Site, Winston-Salem
Galderma Investigational Site, Warren
Galderma Investigational Site, Hazleton
Galderma Investigational Site, Hershey
Galderma Investigational Site, Simpsonville
Galderma Investigational Site, Arlington
Galderma Investigational Site, Austin
Galderma Investigational Site, College Station
Galderma Investigational Site, Houston
Galderma Investigational Site, Lubbock
Galderma Investigational Site, San Antonio
Galderma Investigational Site, Barrie
Galderma Investigational Site, North Bay
Galderma Investigational Site, Windsor
Galderma Investigational Site, Québec
Galderma Investigational Site, Aibonito
Galderma Investigational Site, Carolina
Lead Sponsor
Galderma R&D
INDUSTRY